ES2038724T3 - Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas. - Google Patents

Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas.

Info

Publication number
ES2038724T3
ES2038724T3 ES198888112377T ES88112377T ES2038724T3 ES 2038724 T3 ES2038724 T3 ES 2038724T3 ES 198888112377 T ES198888112377 T ES 198888112377T ES 88112377 T ES88112377 T ES 88112377T ES 2038724 T3 ES2038724 T3 ES 2038724T3
Authority
ES
Spain
Prior art keywords
radiosensitizers
preparing
procedure
tumor cells
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888112377T
Other languages
English (en)
Spanish (es)
Inventor
Mark James Suto
Leslie Morton Werbel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2038724T3 publication Critical patent/ES2038724T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES198888112377T 1987-07-31 1988-07-29 Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas. Expired - Lifetime ES2038724T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/080,280 US4797397A (en) 1987-07-31 1987-07-31 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells

Publications (1)

Publication Number Publication Date
ES2038724T3 true ES2038724T3 (es) 1993-08-01

Family

ID=22156378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888112377T Expired - Lifetime ES2038724T3 (es) 1987-07-31 1988-07-29 Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas.

Country Status (7)

Country Link
US (1) US4797397A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0302416B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6463576A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE71094T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3867368D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2038724T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3003503T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
US5036096A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
US5073639A (en) * 1988-11-25 1991-12-17 Warner-Lambert Company Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US5036089A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
US5432088A (en) * 1992-03-24 1995-07-11 The Toro Company Method and apparatus for aerobic composting
USD338756S (en) 1992-03-24 1993-08-24 The Toro Company Compost bin
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US6252087B1 (en) 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
RU2136628C1 (ru) * 1997-10-28 1999-09-10 Государственный научный центр Российской Федерации Всероссийский научно-исследовательский институт неорганических материалов им.акад.А.А.Бочвара СПОСОБ ПОЛУЧЕНИЯ ПОРОШКОВ СВЕРХПРОВОДЯЩЕЙ КЕРАМИКИ Bi - Pb - Sr - Ca - Cu - O
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20040191843A1 (en) * 2003-02-03 2004-09-30 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
US20040202694A1 (en) * 2003-04-11 2004-10-14 Vascular Control Systems, Inc. Embolic occlusion of uterine arteries
EP1838305A1 (en) 2005-01-21 2007-10-03 Richard H. Matthews Radiosensitizer formulations comprising nitrohistidine derivatives
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
US7842278B2 (en) * 2006-10-27 2010-11-30 Natural Pharmacia International, Inc. Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
WO2008090732A1 (ja) 2007-01-26 2008-07-31 Pola Pharma Inc. 医薬組成物
CN102933258A (zh) * 2010-03-01 2013-02-13 因特奥普医药公司 与含氧量低的细胞敏化剂联用的放疗
US9084806B2 (en) * 2012-11-12 2015-07-21 Research & Business Foundation Sungkyunkwan University Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
EP0095906B1 (en) * 1982-05-27 1986-10-22 National Research Development Corporation Improvements relating to compounds useful in radiotherapy or chemotherapy

Also Published As

Publication number Publication date
GR3003503T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-16
EP0302416B1 (en) 1992-01-02
US4797397A (en) 1989-01-10
ATE71094T1 (de) 1992-01-15
JPS6463576A (en) 1989-03-09
DE3867368D1 (de) 1992-02-13
EP0302416A1 (en) 1989-02-08

Similar Documents

Publication Publication Date Title
ES2038724T3 (es) Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas.
CA1019975A (en) Classifying biological cells by fluorescent radiation using split laser beam
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
IT1141321B (it) Procedimento per ottenere copoliesteri carbonati
ES2137932T3 (es) Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
NL7810911A (nl) Ct aftaster met gereduceerde stralingsdoses.
AT336143B (de) Rontgenanode
RO86704A (ro) Procedeu pentru arderea unor produse care contin carbon
ATA480975A (de) Rontgenanode
DE3376295D1 (en) Pharmaceutical composition containing adenosine derivatives for use in treating tumours
ES426543A1 (es) Un procedimiento para la preparacion de nuevos derivados deacido micofenolico.
IT7828318A0 (it) Disposizione per la generazione ed irradiazione di microonde.
AR219561A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-piperidino-6,7-dialcoxi-ftalazina utiles como agentes terapeuticos
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
DE3771304D1 (de) Geraet zur tomographie mittels gamma-strahlung.
ATA622377A (de) Roentgenstrahlungsgenerator
ES2004218A6 (es) Procedimiento para preparar derivados de purina
DE68910980D1 (de) Schneiden mittels strahlung hoher energie.
FR2318137A1 (fr) Procede de preparation d'ethers perfluores par irradiation lumineuse de perfluoro-cetones
ES412270A1 (es) Metodo para preparar arabinofuranosil citosinas.
ES485733A1 (es) Procedimiento para la obtencion de derivados de esteres de 1,1,2-trifenilalqueno
ES421343A1 (es) Procedimiento para la preparacion de ureidos provistos de grupos de fosforo y glicidilo.
DK223090D0 (da) Anvendelse af 1,2,4-benzotriazinoxider som straalingssensibiliserende midler og selektive cytotoksiske midler
DK455487D0 (da) 13alfa-alkylgonan-delta9(11)-5,10-epoxider og fremgangsmaade til fremstilling deraf
SE8704066L (sv) Sterila geler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302416

Country of ref document: ES